| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | microtubule-based movement | CATSPERE MAP1A DNAH10 MAP1B CENPE SPG11 RSPH6A DNAH7 FSIP2 MET DST BSN PCM1 CFAP46 | 5.82e-06 | 493 | 138 | 14 | GO:0007018 |
| GeneOntologyBiologicalProcess | negative regulation of catabolic process | NRG1 OGT MAP1A MYCBP2 GSK3A RRAGC MET SF3B3 TOB1 N4BP1 EIF4G3 RPL5 | 2.50e-05 | 418 | 138 | 12 | GO:0009895 |
| GeneOntologyBiologicalProcess | regulation of organelle organization | MAP1A MAP1B MYCBP2 CENPE CENPF CARMIL1 TOGARAM2 NBN GRIK5 ODF2 NEB GSK3A SLIT2 MET PBRM1 RESF1 MKI67 PLCB1 PRKCQ EIF4G3 SCIN CNOT1 BAIAP2L2 | 2.79e-05 | 1342 | 138 | 23 | GO:0033043 |
| GeneOntologyBiologicalProcess | microtubule-based process | CATSPERE MAP1A DNAH10 MAP1B CENPE TOGARAM2 SPG11 TACC2 RSPH6A ODF2 DNAH7 GSK3A FSIP2 MET DST BRCA2 BSN PCM1 CFAP46 | 8.18e-05 | 1058 | 138 | 19 | GO:0007017 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | MAP1A MAP1B CENPE TOGARAM2 TACC2 RSPH6A ODF2 DNAH7 GSK3A FSIP2 MET DST BRCA2 PCM1 CFAP46 | 9.81e-05 | 720 | 138 | 15 | GO:0000226 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | USP50 NRG1 SGIP1 MAP1B CENPE NTF3 CARMIL1 ITSN1 NBN FNBP1L GSK3A ABCB4 SLIT2 MET LRRN3 RESF1 PLCB1 PRKCQ EIF4G3 SCIN CNOT1 BAIAP2L2 | 1.07e-04 | 1366 | 138 | 22 | GO:0051130 |
| GeneOntologyBiologicalProcess | negative regulation of protein metabolic process | NRG1 OGT MAP1A MYCBP2 NTF3 PARP14 YWHAB PTPRT SLIT2 MET SERPINA1 SF3B3 TOB1 PLAA ERRFI1 N4BP1 PLEC CNOT1 RPL5 | 1.18e-04 | 1088 | 138 | 19 | GO:0051248 |
| GeneOntologyBiologicalProcess | positive regulation of organelle organization | MAP1B CENPE CARMIL1 NBN GSK3A MET RESF1 PLCB1 PRKCQ EIF4G3 SCIN CNOT1 BAIAP2L2 | 1.29e-04 | 574 | 138 | 13 | GO:0010638 |
| GeneOntologyBiologicalProcess | cardiac muscle thin filament assembly | 1.33e-04 | 3 | 138 | 2 | GO:0071691 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component biogenesis | USP50 NRG1 MAP1B CARMIL1 FNBP1L SLIT2 MET LRRN3 RESF1 HGS PRKCQ CNOT1 BAIAP2L2 | 1.48e-04 | 582 | 138 | 13 | GO:0044089 |
| GeneOntologyCellularComponent | cilium | ANO2 EVC2 CATSPERE MAP1A DNAH10 MAP1B RIBC2 PDE6B CENPF TOGARAM2 RSPH6A ODF2 PTCH1 DNAH7 FSIP2 MET PHYH CNGA3 PCM1 CFAP46 | 2.92e-06 | 898 | 142 | 20 | GO:0005929 |
| GeneOntologyCellularComponent | postsynapse | USP50 NRG1 OGT ANK2 MAP1A MAP1B MYO9B ITSN1 GRIA1 NBEA GRIK5 SLC1A3 PTPRT GSK3A MET DST PLCB1 PLCB3 BSN MAPK10 RPL5 | 5.32e-06 | 1018 | 142 | 21 | GO:0098794 |
| GeneOntologyCellularComponent | asymmetric synapse | USP50 NRG1 OGT ANK2 MAP1A MAP1B GRIA1 GRIK5 PTPRT DST BSN MAPK10 RPL5 | 2.32e-05 | 477 | 142 | 13 | GO:0032279 |
| GeneOntologyCellularComponent | axon | NRG1 MAP1A MAP1B MYCBP2 NTF3 ITSN1 GRIA1 SPG11 GRIK5 PTCH1 GSK3A SLIT2 DST PLEC POTEJ BSN EXOC7 CNGA3 | 3.51e-05 | 891 | 142 | 18 | GO:0030424 |
| GeneOntologyCellularComponent | clathrin coat | 3.90e-05 | 56 | 142 | 5 | GO:0030118 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | USP50 NRG1 OGT ANK2 MAP1A MAP1B GRIA1 GRIK5 PTPRT DST BSN MAPK10 RPL5 | 5.98e-05 | 523 | 142 | 13 | GO:0098984 |
| GeneOntologyCellularComponent | postsynaptic density | USP50 NRG1 ANK2 MAP1A MAP1B GRIA1 GRIK5 PTPRT DST BSN MAPK10 RPL5 | 6.09e-05 | 451 | 142 | 12 | GO:0014069 |
| GeneOntologyCellularComponent | dendrite | USP50 MAP1A MAP1B NTF3 ITSN1 GRIA1 SPG11 GRIK5 PTCH1 SLC1A3 GSK3A ITPR3 SLIT2 MET PLEC BSN CNGA3 | 7.45e-05 | 858 | 142 | 17 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | USP50 MAP1A MAP1B NTF3 ITSN1 GRIA1 SPG11 GRIK5 PTCH1 SLC1A3 GSK3A ITPR3 SLIT2 MET PLEC BSN CNGA3 | 7.67e-05 | 860 | 142 | 17 | GO:0097447 |
| GeneOntologyCellularComponent | postsynaptic specialization | USP50 NRG1 ANK2 MAP1A MAP1B GRIA1 GRIK5 PTPRT DST BSN MAPK10 RPL5 | 1.70e-04 | 503 | 142 | 12 | GO:0099572 |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 3.24e-04 | 317 | 142 | 9 | GO:0032838 | |
| GeneOntologyCellularComponent | non-motile cilium | 3.92e-04 | 196 | 142 | 7 | GO:0097730 | |
| GeneOntologyCellularComponent | Z disc | 5.87e-04 | 151 | 142 | 6 | GO:0030018 | |
| GeneOntologyCellularComponent | somatodendritic compartment | USP50 OGT MAP1A MAP1B NTF3 ITSN1 GRIA1 SPG11 GRIK5 PTCH1 SLC1A3 GSK3A ITPR3 SLIT2 MET PLEC BSN MAPK10 CNGA3 | 6.59e-04 | 1228 | 142 | 19 | GO:0036477 |
| GeneOntologyCellularComponent | coated membrane | 7.88e-04 | 106 | 142 | 5 | GO:0048475 | |
| GeneOntologyCellularComponent | membrane coat | 7.88e-04 | 106 | 142 | 5 | GO:0030117 | |
| GeneOntologyCellularComponent | cytoplasmic region | 8.09e-04 | 360 | 142 | 9 | GO:0099568 | |
| GeneOntologyCellularComponent | midbody | 8.20e-04 | 222 | 142 | 7 | GO:0030496 | |
| GeneOntologyCellularComponent | I band | 9.63e-04 | 166 | 142 | 6 | GO:0031674 | |
| GeneOntologyCellularComponent | supramolecular fiber | ANK2 NEBL MAP1A DNAH10 MAP1B CENPE RIBC2 MYO9B CARMIL1 TOGARAM2 ODF2 NEB DNAH7 GSK3A PGM1 DST PLEC POTEJ | 1.07e-03 | 1179 | 142 | 18 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | ANK2 NEBL MAP1A DNAH10 MAP1B CENPE RIBC2 MYO9B CARMIL1 TOGARAM2 ODF2 NEB DNAH7 GSK3A PGM1 DST PLEC POTEJ | 1.16e-03 | 1187 | 142 | 18 | GO:0099081 |
| GeneOntologyCellularComponent | clathrin adaptor complex | 1.20e-03 | 31 | 142 | 3 | GO:0030131 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 1.23e-03 | 238 | 142 | 7 | GO:0097729 | |
| GeneOntologyCellularComponent | apical dendrite | 1.32e-03 | 32 | 142 | 3 | GO:0097440 | |
| GeneOntologyCellularComponent | neuronal cell body | OGT MAP1A MAP1B ITSN1 GRIA1 GRIK5 SLC1A3 GSK3A ITPR3 SLIT2 MET BSN MAPK10 CNGA3 | 1.67e-03 | 835 | 142 | 14 | GO:0043025 |
| GeneOntologyCellularComponent | ciliary transition fiber | 1.99e-03 | 10 | 142 | 2 | GO:0097539 | |
| GeneOntologyCellularComponent | inner dynein arm | 1.99e-03 | 10 | 142 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | clathrin vesicle coat | 2.18e-03 | 38 | 142 | 3 | GO:0030125 | |
| GeneOntologyCellularComponent | hemidesmosome | 2.42e-03 | 11 | 142 | 2 | GO:0030056 | |
| GeneOntologyCellularComponent | aminoacyl-tRNA synthetase multienzyme complex | 2.89e-03 | 12 | 142 | 2 | GO:0017101 | |
| GeneOntologyCellularComponent | axoneme | 2.94e-03 | 207 | 142 | 6 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 3.01e-03 | 208 | 142 | 6 | GO:0097014 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | MAP1A DNAH10 MAP1B CENPE RIBC2 MYO9B CARMIL1 TOGARAM2 ODF2 DNAH7 GSK3A DST PLEC POTEJ | 3.27e-03 | 899 | 142 | 14 | GO:0099513 |
| GeneOntologyCellularComponent | sperm principal piece | 3.32e-03 | 44 | 142 | 3 | GO:0097228 | |
| GeneOntologyCellularComponent | microtubule | MAP1A DNAH10 MAP1B CENPE RIBC2 TOGARAM2 ODF2 DNAH7 GSK3A DST | 3.53e-03 | 533 | 142 | 10 | GO:0005874 |
| GeneOntologyCellularComponent | postsynaptic cytosol | 3.53e-03 | 45 | 142 | 3 | GO:0099524 | |
| GeneOntologyCellularComponent | 9+0 non-motile cilium | 3.95e-03 | 153 | 142 | 5 | GO:0097731 | |
| MousePheno | abnormal synaptic transmission | USP50 NRG1 EVC2 ANK2 TTC28 ITSN1 GRIA1 NBEA GRIK5 SLC1A3 PTPRT TASOR2 DHX8 EPG5 PHYH MGAT2 PBRM1 PLAA NUFIP2 PLCB1 PRKCQ BSN BAIAP2L2 PCM1 | 9.56e-06 | 1070 | 119 | 24 | MP:0003635 |
| MousePheno | abnormal synaptic physiology | USP50 NRG1 EVC2 ANK2 TTC28 ITSN1 GRIA1 NBEA GRIK5 SLC1A3 PTPRT TASOR2 DHX8 EPG5 PHYH MGAT2 PBRM1 PLAA NUFIP2 PLCB1 PRKCQ BSN BAIAP2L2 PCM1 | 1.05e-05 | 1076 | 119 | 24 | MP:0021009 |
| MousePheno | abnormal PNS synaptic transmission | 1.09e-05 | 35 | 119 | 5 | MP:0002913 | |
| MousePheno | abnormal locomotor coordination | NRG1 OSTM1 MAP1A MAP1B NTF3 ITSN1 GRIA1 SPG11 NEB GSK3A EPG5 PHYH PBRM1 DST PLAA HGS ERRFI1 BSN BAIAP2L2 | 1.13e-05 | 726 | 119 | 19 | MP:0003312 |
| MousePheno | abnormal somatic motor system morphology | 1.98e-05 | 98 | 119 | 7 | MP:0001051 | |
| MousePheno | abnormal CNS synaptic transmission | USP50 NRG1 EVC2 ANK2 TTC28 ITSN1 GRIA1 NBEA GRIK5 SLC1A3 PTPRT TASOR2 DHX8 EPG5 PHYH PBRM1 PLAA NUFIP2 PLCB1 BSN BAIAP2L2 PCM1 | 2.57e-05 | 985 | 119 | 22 | MP:0002206 |
| MousePheno | abnormal prepulse inhibition | USP50 NRG1 EVC2 TTC28 ITSN1 GRIA1 TASOR2 DHX8 EPG5 PHYH PBRM1 NUFIP2 PLCB1 BAIAP2L2 PCM1 | 5.55e-05 | 542 | 119 | 15 | MP:0003088 |
| MousePheno | taste/olfaction phenotype | 9.45e-05 | 125 | 119 | 7 | MP:0005394 | |
| MousePheno | abnormal synapse morphology | 1.25e-04 | 224 | 119 | 9 | MP:0009538 | |
| MousePheno | abnormal spinal cord morphology | 1.30e-04 | 278 | 119 | 10 | MP:0000955 | |
| MousePheno | abnormal gait | OSTM1 MAP1B ITSN1 GRIA1 SPG11 NEB GSK3A EPG5 PHYH PBRM1 DST PLAA ERRFI1 BAIAP2L2 | 1.34e-04 | 520 | 119 | 14 | MP:0001406 |
| MousePheno | abnormal motor coordination/balance | ANK2 MAP1A MAP1B NTF3 ITSN1 SPG11 AK9 SLC1A3 EPG5 MET PHYH MGAT2 DST PLAA HGS TRMT1L BSN MAPK10 VPS13B | 1.39e-04 | 873 | 119 | 19 | MP:0001516 |
| MousePheno | abnormal glossopharyngeal ganglion morphology | 1.49e-04 | 32 | 119 | 4 | MP:0001096 | |
| MousePheno | decreased prepulse inhibition | USP50 EVC2 TTC28 ITSN1 GRIA1 DHX8 EPG5 PHYH PBRM1 NUFIP2 PLCB1 BAIAP2L2 PCM1 | 1.59e-04 | 464 | 119 | 13 | MP:0009142 |
| MousePheno | abnormal visual acuity | 1.62e-04 | 13 | 119 | 3 | MP:0011832 | |
| MousePheno | decreased visual acuity | 1.62e-04 | 13 | 119 | 3 | MP:0006149 | |
| MousePheno | abnormal nervous system tract morphology | 2.10e-04 | 189 | 119 | 8 | MP:0000778 | |
| MousePheno | abnormal cerebellar cortex morphology | 2.41e-04 | 300 | 119 | 10 | MP:0004097 | |
| MousePheno | abnormal muscle spindle morphology | 2.54e-04 | 15 | 119 | 3 | MP:0004069 | |
| MousePheno | abnormal skeletal muscle mechanoreceptor morphology | 2.54e-04 | 15 | 119 | 3 | MP:0000990 | |
| MousePheno | abnormal sensory capabilities/reflexes/nociception | ABCC3 NRG1 SGIP1 MAP1B PDE6B NTF3 ITSN1 GRIA1 NBEA SPG11 GRIK5 GSK3A EPG5 RBM22 DST PLAA KCNJ13 NUFIP2 PLCB1 PLCB2 PLCB3 BSN BAIAP2L2 VPS13B PCM1 XPOT | 2.63e-04 | 1486 | 119 | 26 | MP:0002067 |
| MousePheno | abnormal Purkinje cell morphology | 3.52e-04 | 204 | 119 | 8 | MP:0000877 | |
| MousePheno | abnormal brain size | 3.53e-04 | 375 | 119 | 11 | MP:0000771 | |
| MousePheno | unresponsive to tactile stimuli | 3.89e-04 | 73 | 119 | 5 | MP:0001491 | |
| MousePheno | abnormal cerebellar layer morphology | 4.11e-04 | 263 | 119 | 9 | MP:0009956 | |
| MousePheno | increased integument system tumor incidence | 4.69e-04 | 76 | 119 | 5 | MP:0010293 | |
| MousePheno | abnormal reflex | NRG1 SGIP1 MAP1B PDE6B NTF3 ITSN1 GRIA1 NBEA SPG11 GRIK5 GSK3A EPG5 RBM22 DST PLAA KCNJ13 NUFIP2 PLCB1 BSN BAIAP2L2 VPS13B PCM1 XPOT | 5.11e-04 | 1294 | 119 | 23 | MP:0001961 |
| MousePheno | increased circulating amylase level | 5.32e-04 | 119 | 119 | 6 | MP:0008806 | |
| Domain | PLC-beta_C | 4.21e-07 | 3 | 141 | 3 | PF08703 | |
| Domain | PLC-beta_C | 4.21e-07 | 3 | 141 | 3 | IPR014815 | |
| Domain | PLC-beta | 1.68e-06 | 4 | 141 | 3 | IPR016280 | |
| Domain | PLC-beta_CS | 1.69e-04 | 3 | 141 | 2 | IPR009535 | |
| Domain | MAP1 | 1.69e-04 | 3 | 141 | 2 | IPR026074 | |
| Domain | DUF1154 | 1.69e-04 | 3 | 141 | 2 | PF06631 | |
| Domain | EF-hand_like | 1.79e-04 | 15 | 141 | 3 | PF09279 | |
| Domain | PI-PLC-Y | 1.79e-04 | 15 | 141 | 3 | PF00387 | |
| Domain | PLCYc | 1.79e-04 | 15 | 141 | 3 | SM00149 | |
| Domain | PLipase_C_Pinositol-sp_Y | 1.79e-04 | 15 | 141 | 3 | IPR001711 | |
| Domain | PIPLC_Y_DOMAIN | 1.79e-04 | 15 | 141 | 3 | PS50008 | |
| Domain | PI-PLC_fam | 1.79e-04 | 15 | 141 | 3 | IPR001192 | |
| Domain | PLC_EF-hand-like | 1.79e-04 | 15 | 141 | 3 | IPR015359 | |
| Domain | SH3_9 | 3.10e-04 | 78 | 141 | 5 | PF14604 | |
| Domain | PI-PLC-X | 3.16e-04 | 18 | 141 | 3 | PF00388 | |
| Domain | PLCXc | 3.16e-04 | 18 | 141 | 3 | SM00148 | |
| Domain | Nebulin | 3.36e-04 | 4 | 141 | 2 | PF00880 | |
| Domain | NEBULIN | 3.36e-04 | 4 | 141 | 2 | PS51216 | |
| Domain | NEBU | 3.36e-04 | 4 | 141 | 2 | SM00227 | |
| Domain | Nebulin | 3.36e-04 | 4 | 141 | 2 | IPR013998 | |
| Domain | Nebulin_repeat | 3.36e-04 | 4 | 141 | 2 | IPR000900 | |
| Domain | PIPLC_X_DOMAIN | 3.74e-04 | 19 | 141 | 3 | PS50007 | |
| Domain | PLipase_C_PInositol-sp_X_dom | 3.74e-04 | 19 | 141 | 3 | IPR000909 | |
| Domain | AAA | 7.90e-04 | 144 | 141 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 7.90e-04 | 144 | 141 | 6 | IPR003593 | |
| Domain | - | 8.32e-04 | 6 | 141 | 2 | 3.90.1290.10 | |
| Domain | - | 8.58e-04 | 25 | 141 | 3 | 3.20.20.190 | |
| Domain | PLC-like_Pdiesterase_TIM-brl | 8.58e-04 | 25 | 141 | 3 | IPR017946 | |
| Domain | Plectin | 1.16e-03 | 7 | 141 | 2 | PF00681 | |
| Domain | Plectin_repeat | 1.16e-03 | 7 | 141 | 2 | IPR001101 | |
| Domain | PLEC | 1.16e-03 | 7 | 141 | 2 | SM00250 | |
| Domain | SH3 | 1.28e-03 | 216 | 141 | 7 | PS50002 | |
| Domain | SH3_domain | 1.43e-03 | 220 | 141 | 7 | IPR001452 | |
| Domain | TPR_REGION | 1.59e-03 | 165 | 141 | 6 | PS50293 | |
| Domain | TPR | 1.59e-03 | 165 | 141 | 6 | PS50005 | |
| Domain | EH | 2.98e-03 | 11 | 141 | 2 | PS50031 | |
| Domain | EH | 2.98e-03 | 11 | 141 | 2 | SM00027 | |
| Domain | EH_dom | 2.98e-03 | 11 | 141 | 2 | IPR000261 | |
| Domain | Cullin_repeat-like_dom | 3.55e-03 | 12 | 141 | 2 | IPR016159 | |
| Domain | ABC_transporter_CS | 3.90e-03 | 42 | 141 | 3 | IPR017871 | |
| Domain | C2 | 4.48e-03 | 142 | 141 | 5 | PS50004 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.85e-03 | 14 | 141 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 4.85e-03 | 14 | 141 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 4.85e-03 | 14 | 141 | 2 | IPR013602 | |
| Domain | DHC_N2 | 4.85e-03 | 14 | 141 | 2 | PF08393 | |
| Domain | MT | 4.85e-03 | 14 | 141 | 2 | PF12777 | |
| Domain | AAA_8 | 4.85e-03 | 14 | 141 | 2 | PF12780 | |
| Domain | - | 5.33e-03 | 148 | 141 | 5 | 2.60.40.150 | |
| Domain | DHC_fam | 5.57e-03 | 15 | 141 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 5.57e-03 | 15 | 141 | 2 | PF03028 | |
| Domain | Dynein_heavy_dom | 5.57e-03 | 15 | 141 | 2 | IPR004273 | |
| Domain | ABC_tran | 5.68e-03 | 48 | 141 | 3 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 5.68e-03 | 48 | 141 | 3 | PS50893 | |
| Domain | SH3 | 6.01e-03 | 216 | 141 | 6 | SM00326 | |
| Domain | ABC_TRANSPORTER_1 | 6.02e-03 | 49 | 141 | 3 | PS00211 | |
| Domain | MAM_1 | 6.34e-03 | 16 | 141 | 2 | PS00740 | |
| Domain | ABC_transporter-like | 6.37e-03 | 50 | 141 | 3 | IPR003439 | |
| Domain | MAM | 7.15e-03 | 17 | 141 | 2 | SM00137 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 7.64e-07 | 10 | 112 | 4 | M47661 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.19e-06 | 11 | 112 | 4 | M49033 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY | 2.55e-06 | 13 | 112 | 4 | M47656 | |
| Pathway | WP_GPR40_PATHWAY | 4.82e-06 | 15 | 112 | 4 | M39526 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 9.60e-06 | 6 | 112 | 3 | M47548 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 1.66e-05 | 20 | 112 | 4 | M47688 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CASR_PTH_SIGNALING_PATHWAY | 1.67e-05 | 7 | 112 | 3 | M47505 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY | 2.04e-05 | 21 | 112 | 4 | M47689 | |
| Pathway | WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA | 2.47e-05 | 22 | 112 | 4 | M39795 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.47e-05 | 22 | 112 | 4 | M47690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.47e-05 | 22 | 112 | 4 | M47675 | |
| Pathway | REACTOME_ACETYLCHOLINE_REGULATES_INSULIN_SECRETION | 2.66e-05 | 8 | 112 | 3 | MM15032 | |
| Pathway | REACTOME_FATTY_ACIDS_BOUND_TO_GPR40_FFAR1_REGULATE_INSULIN_SECRETION | 2.66e-05 | 8 | 112 | 3 | M27356 | |
| Pathway | REACTOME_FATTY_ACIDS_BOUND_TO_GPR40_FFAR1_REGULATE_INSULIN_SECRETION | 2.66e-05 | 8 | 112 | 3 | MM15100 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.98e-05 | 23 | 112 | 4 | M47676 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TAC3_TACR3_PLC_PKC_SIGNALING_PATHWAY | 5.63e-05 | 10 | 112 | 3 | M47644 | |
| Pathway | REACTOME_ACETYLCHOLINE_REGULATES_INSULIN_SECRETION | 5.63e-05 | 10 | 112 | 3 | M1825 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 6.71e-05 | 54 | 112 | 5 | M26911 | |
| Pathway | REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION | 7.69e-05 | 11 | 112 | 3 | M27317 | |
| Pathway | REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION | 7.69e-05 | 11 | 112 | 3 | MM15035 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KISS1_KISS1R_PLCB_PKC_SIGNALING_PATHWAY | 7.69e-05 | 11 | 112 | 3 | M47637 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 8.82e-05 | 30 | 112 | 4 | M18193 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TRH_TRHR_PLCB_PKC_SIGNALING_PATHWAY | 1.02e-04 | 12 | 112 | 3 | M47649 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TSH_DUOX2_TG_SIGNALING_PATHWAY | 1.02e-04 | 12 | 112 | 3 | M47628 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 1.14e-04 | 32 | 112 | 4 | MM15143 | |
| Pathway | REACTOME_CA2_PATHWAY | 1.31e-04 | 62 | 112 | 5 | M27321 | |
| Pathway | KEGG_LONG_TERM_DEPRESSION | 2.32e-04 | 70 | 112 | 5 | M8232 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 2.32e-04 | 70 | 112 | 5 | M3115 | |
| Pathway | WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY | 2.51e-04 | 39 | 112 | 4 | M39905 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABBERANT_ATXN2_3_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.65e-04 | 18 | 112 | 3 | M47659 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCL12_CXCR4_PKC_ERK_SIGNALING_PATHAWAY | 4.31e-04 | 19 | 112 | 3 | M47596 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 4.31e-04 | 19 | 112 | 3 | M47543 | |
| Pathway | REACTOME_CA2_PATHWAY | 4.38e-04 | 45 | 112 | 4 | MM15040 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GNRH_GNRHR_PLCB_PKC_SIGNALING_PATHWAY | 5.85e-04 | 21 | 112 | 3 | M47638 | |
| Pathway | REACTOME_PRESYNAPTIC_FUNCTION_OF_KAINATE_RECEPTORS | 5.85e-04 | 21 | 112 | 3 | M27409 | |
| Pathway | REACTOME_PRESYNAPTIC_FUNCTION_OF_KAINATE_RECEPTORS | 5.85e-04 | 21 | 112 | 3 | MM15159 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 5.85e-04 | 21 | 112 | 3 | M47542 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY | 6.56e-04 | 50 | 112 | 4 | M47951 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 7.44e-04 | 90 | 112 | 5 | M6467 | |
| Pathway | WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING | 8.71e-04 | 140 | 112 | 6 | M42572 | |
| Pathway | BIOCARTA_MRP_PATHWAY | 9.19e-04 | 6 | 112 | 2 | M22078 | |
| Pathway | WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION | 9.89e-04 | 25 | 112 | 3 | M39384 | |
| Pathway | WP_HIPPO_SIGNALING_REGULATION | 1.09e-03 | 98 | 112 | 5 | M39830 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CCR5_GNB_G_PLCB_G_PKC_SIGNALING_PATHWAY | 1.11e-03 | 26 | 112 | 3 | M47557 | |
| Pathway | REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL | 1.11e-03 | 26 | 112 | 3 | M27053 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 1.24e-03 | 205 | 112 | 7 | M752 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 1.25e-03 | 101 | 112 | 5 | M1979 | |
| Pathway | WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM | 1.31e-03 | 60 | 112 | 4 | M40048 | |
| Pathway | PID_IL8_CXCR1_PATHWAY | 1.38e-03 | 28 | 112 | 3 | M252 | |
| Pathway | REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL | 1.38e-03 | 28 | 112 | 3 | MM14711 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.38e-03 | 28 | 112 | 3 | M47508 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 1.39e-03 | 61 | 112 | 4 | MM15071 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 1.39e-03 | 270 | 112 | 8 | M15514 | |
| Pathway | PID_ENDOTHELIN_PATHWAY | 1.57e-03 | 63 | 112 | 4 | M8 | |
| Pathway | WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS | 1.70e-03 | 30 | 112 | 3 | M42578 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 1.86e-03 | 66 | 112 | 4 | MM15925 | |
| Pathway | PID_AR_NONGENOMIC_PATHWAY | 1.87e-03 | 31 | 112 | 3 | M213 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY | 1.87e-03 | 31 | 112 | 3 | M47554 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | CUL1 SYNRG OGT MAP1A TTC28 CENPE MYO9B ITSN1 NBN TACC2 FNBP1L UBN2 GSK3A RBM22 SF3B3 RESF1 BRCA2 POTEJ BSN SCIN PCM1 | 4.86e-14 | 588 | 143 | 21 | 38580884 |
| Pubmed | SGIP1 ANK2 MAP1A MAP1B MYCBP2 ITSN1 NBEA FNBP1L SLC1A3 DST NUFIP2 PLCB1 PLEC BSN EIF4G3 MAPK10 PCM1 | 9.53e-14 | 347 | 143 | 17 | 17114649 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | CUL1 NRG1 COL6A6 CENPE CENPF MARS1 CARMIL1 TOGARAM2 NBEA SPG11 AK9 NEB TTC6 TTC19 SERPINA1 TIAL1 ZC3H4 CNOT1 XPOT | 2.58e-13 | 497 | 143 | 19 | 36774506 |
| Pubmed | OGT SGIP1 TCF20 ANK2 MYCBP2 CENPE CENPF ITSN1 UBR4 GRIA1 NBEA GRIK5 UBN2 YWHAB SLC1A3 PBRM1 DST ZC3H4 NUFIP2 PLCB1 BSN CNOT1 PCM1 | 1.10e-11 | 963 | 143 | 23 | 28671696 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | THOC1 SYNRG MAP1A MAP1B MYCBP2 NBN FNBP1L ANKHD1 UBN2 DHX8 SLIT2 RBM22 SF3B3 ZC3H4 NUFIP2 MKI67 PLEC EIF4G3 CNOT1 RPL5 | 2.15e-11 | 724 | 143 | 20 | 36232890 |
| Pubmed | TCF20 MAP1B MYCBP2 CENPF UBR4 ANKHD1 TASOR2 DHX8 ITPR3 PBRM1 DST NUFIP2 MKI67 PLEC EIF4G3 CNOT1 RPL5 PCM1 XPOT | 2.94e-11 | 653 | 143 | 19 | 22586326 | |
| Pubmed | ABCC3 FAT4 TCF20 TTC28 UBR4 NBN NBEA NEB SLC1A3 DNAH7 ITPR3 RBM22 PBRM1 PLCB1 MAIP1 POTEJ BSN CNOT1 | 1.66e-10 | 638 | 143 | 18 | 31182584 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | THOC1 TCF20 MAP1B MYCBP2 CENPF MYO9B MARS1 YWHAB DHX8 ITPR3 SLIT2 PBRM1 SF3B3 DST TIAL1 ZC3H4 MKI67 PLEC SCIN CNOT1 RPL5 PCM1 | 2.41e-10 | 1024 | 143 | 22 | 24711643 |
| Pubmed | ANK2 MAP1B CENPF ITSN1 UBR4 GRIA1 SPG11 ZBTB41 FNBP1L ODF2 NEB YWHAB TASOR2 ABCB4 RBM22 SF3B3 DST TIAL1 UGGT2 ZNF84 PLEC POTEJ BSN EIF4G3 CFAP46 | 1.08e-09 | 1442 | 143 | 25 | 35575683 | |
| Pubmed | SYNRG SGIP1 ANK2 MAP1A MAP1B MYCBP2 UBR4 GRIA1 NBEA TACC2 SLC1A3 GSK3A MET PLAA NUFIP2 PLCB1 PLEC BSN EIF4G3 CNOT1 RPL5 PCM1 | 1.73e-09 | 1139 | 143 | 22 | 36417873 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SYNRG ANK2 NEBL MAP1A MAP1B MARS1 CARMIL1 NBN TACC2 ANKHD1 MOB3A DST ZC3H4 NUFIP2 MKI67 EIF4G3 SCIN RPL5 PCM1 | 1.09e-08 | 934 | 143 | 19 | 33916271 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | THOC1 EED MAP1B MYCBP2 CENPE CENPF MYO9B TACC2 DHX8 PBRM1 NUFIP2 MKI67 TRMT1L EIF4G3 EXOC7 CNOT1 RPL5 | 1.71e-08 | 759 | 143 | 17 | 35915203 |
| Pubmed | OGT TCF20 TTC28 MYCBP2 CENPF UBR4 ANKHD1 DST RESF1 BRCA2 PLEC CNOT1 PCM1 | 2.12e-08 | 418 | 143 | 13 | 34709266 | |
| Pubmed | 3.40e-08 | 9 | 143 | 4 | 15623527 | ||
| Pubmed | 4.37e-08 | 24 | 143 | 5 | 10843712 | ||
| Pubmed | TCF20 NEBL TTC28 MYCBP2 CENPE ITSN1 NBN SPG11 P3H4 DHX8 HGS NUFIP2 UGGT2 N4BP1 EXOC7 PCM1 | 6.59e-08 | 733 | 143 | 16 | 34672954 | |
| Pubmed | OGT SGIP1 ANK2 MAP1A MAP1B MARS1 CARMIL1 ITSN1 GRIA1 NBEA YWHAB SLC1A3 PGM1 SF3B3 DST NUFIP2 PLEC BSN EIF4G3 CNOT1 RPL5 PCM1 | 1.01e-07 | 1431 | 143 | 22 | 37142655 | |
| Pubmed | 2.71e-07 | 4 | 143 | 3 | 9753089 | ||
| Pubmed | 2.71e-07 | 4 | 143 | 3 | 9188725 | ||
| Pubmed | Phospholipase C isozymes selectively couple to specific neurotransmitter receptors. | 2.71e-07 | 4 | 143 | 3 | 9305844 | |
| Pubmed | 2.71e-07 | 4 | 143 | 3 | 15174099 | ||
| Pubmed | Phospholipase C-β1 potentiates glucose-stimulated insulin secretion. | 2.71e-07 | 4 | 143 | 3 | 31268747 | |
| Pubmed | 2.71e-07 | 4 | 143 | 3 | 23006664 | ||
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | MAP1B MYCBP2 ODF2 PTCH1 YWHAB SLIT2 TIAL1 MKI67 CNOT1 GDF11 RPL5 | 3.04e-07 | 358 | 143 | 11 | 32460013 |
| Pubmed | Synergistic Signaling by Light and Acetylcholine in Mouse Iris Sphincter Muscle. | 3.61e-07 | 15 | 143 | 4 | 28578927 | |
| Pubmed | THOC1 EED TTC28 MTF2 UBR4 ITPR3 DST PLAA BRCA2 HGS MKI67 TRMT1L RPL5 PCM1 | 3.99e-07 | 634 | 143 | 14 | 34591612 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SYNRG TCF20 TTC28 MAP1B MYCBP2 CARMIL1 RALGAPB YWHAB DNAH7 GSK3A FSIP2 DST RESF1 PLEC EIF4G3 PCM1 | 5.68e-07 | 861 | 143 | 16 | 36931259 |
| Pubmed | TCF20 MAP1A CENPF ITSN1 NBN YWHAB DHX8 RBM22 DST ZC3H4 HGS TRMT1L | 6.49e-07 | 472 | 143 | 12 | 38943005 | |
| Pubmed | 6.77e-07 | 5 | 143 | 3 | 15611108 | ||
| Pubmed | 6.77e-07 | 5 | 143 | 3 | 11941371 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | THOC1 SYNRG TCF20 MYCBP2 CARMIL1 ITSN1 RALGAPB NBN ODF2 GSK3A ZC3H4 MKI67 PLCB3 PLEC PCM1 | 7.79e-07 | 774 | 143 | 15 | 15302935 |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 8.18e-07 | 123 | 143 | 7 | 26912792 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | OGT MAP1B MYCBP2 MARS1 UBR4 ANKHD1 YWHAB PGM1 SF3B3 DST ZC3H4 NUFIP2 TRMT1L PLEC EIF4G3 EXOC7 CNOT1 RPL5 | 1.26e-06 | 1149 | 143 | 18 | 35446349 |
| Pubmed | 1.35e-06 | 6 | 143 | 3 | 8739298 | ||
| Pubmed | 1.35e-06 | 6 | 143 | 3 | 2841328 | ||
| Pubmed | OGT ANK2 TTC28 MYCBP2 ITSN1 UBR4 NBEA ODF2 YWHAB GSK3A RBM22 ZNF836 DST ZNF84 PLEC EIF4G3 EXOC7 PCM1 XPOT | 1.46e-06 | 1285 | 143 | 19 | 35914814 | |
| Pubmed | 1.55e-06 | 21 | 143 | 4 | 30270038 | ||
| Pubmed | 1.56e-06 | 263 | 143 | 9 | 34702444 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.62e-06 | 341 | 143 | 10 | 32971831 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 1.99e-06 | 271 | 143 | 9 | 32433965 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | FAT4 CENPE CENPF ITSN1 UBR4 NBEA ZBTB41 GRIK5 PARP14 PGM1 DST ERRFI1 PLCB3 CNOT1 | 2.30e-06 | 736 | 143 | 14 | 29676528 |
| Pubmed | Genetic dissection of gustatory sensitivity to bitterness (sucrose octaacetate) in mice. | 2.35e-06 | 7 | 143 | 3 | 10609087 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | SYNRG MAP1A MAP1B NBN TACC2 FNBP1L UBN2 RBM22 RESF1 BRCA2 NUFIP2 | 2.48e-06 | 444 | 143 | 11 | 34795231 |
| Pubmed | SYNRG OGT TCF20 TTC28 MAP1B MYCBP2 NBN ANKHD1 UBN2 NUFIP2 CNOT1 PCM1 | 3.10e-06 | 549 | 143 | 12 | 38280479 | |
| Pubmed | THOC1 EED YWHAB RRAGC ITPR3 DST TIAL1 NUFIP2 MKI67 PLEC POTEJ RPL5 PCM1 | 3.70e-06 | 660 | 143 | 13 | 32780723 | |
| Pubmed | 4.12e-06 | 222 | 143 | 8 | 37071664 | ||
| Pubmed | 4.47e-06 | 27 | 143 | 4 | 20336759 | ||
| Pubmed | 5.61e-06 | 9 | 143 | 3 | 7589147 | ||
| Pubmed | 5.61e-06 | 9 | 143 | 3 | 10501179 | ||
| Pubmed | TCF20 MAP1A ITSN1 NEB YWHAB DST HGS ERRFI1 PLCB1 PLEC MAPK10 | 5.85e-06 | 486 | 143 | 11 | 20936779 | |
| Pubmed | 5.88e-06 | 233 | 143 | 8 | 37704626 | ||
| Pubmed | 6.07e-06 | 234 | 143 | 8 | 36243803 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | THOC1 CUL1 EED OGT TCF20 CENPF MTF2 NBN UBN2 DHX8 ITPR3 RBM22 MSANTD3 PBRM1 SF3B3 DST MKI67 RPL5 | 6.54e-06 | 1294 | 143 | 18 | 30804502 |
| Pubmed | MYCBP2 RALGAPB NBN NBEA ODF2 YWHAB PTPRT GSK3A ITPR3 PTPRM HGS NUFIP2 MKI67 SCIN CNOT1 XPOT | 7.14e-06 | 1049 | 143 | 16 | 27880917 | |
| Pubmed | Expression of phospholipase C isozymes by murine B lymphocytes. | 8.00e-06 | 10 | 143 | 3 | 2033248 | |
| Pubmed | 8.00e-06 | 10 | 143 | 3 | 23295235 | ||
| Pubmed | 9.70e-06 | 513 | 143 | 11 | 25798074 | ||
| Pubmed | Genetic mapping of the human and mouse phospholipase C genes. | 1.02e-05 | 33 | 143 | 4 | 8672127 | |
| Pubmed | 1.03e-05 | 332 | 143 | 9 | 37433992 | ||
| Pubmed | OGT MARS1 ITSN1 ZBTB41 TACC2 PTCH1 ANKHD1 UBN2 SLC1A3 PGM1 RESF1 PLAA PLEC CNOT1 VPS13B XPOT | 1.07e-05 | 1084 | 143 | 16 | 11544199 | |
| Pubmed | Bimodal regulation of the PRC2 complex by USP7 underlies tumorigenesis. | 1.10e-05 | 11 | 143 | 3 | 33849069 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | SYNRG TTC28 CENPE CARMIL1 ITSN1 NBN ODF2 DNAH7 GSK3A BRCA2 HGS PLEC CNOT1 PCM1 | 1.23e-05 | 853 | 143 | 14 | 28718761 |
| Pubmed | 1.31e-05 | 187 | 143 | 7 | 26460568 | ||
| Pubmed | 1.46e-05 | 12 | 143 | 3 | 35472321 | ||
| Pubmed | THOC1 CUL1 OGT NEBL MYO9B MARS1 YWHAB GSK3A DHX8 ITPR3 RBM22 SF3B3 HGS NUFIP2 MKI67 TRMT1L RPL5 | 1.56e-05 | 1247 | 143 | 17 | 27684187 | |
| Pubmed | TTC28 MAP1B MYCBP2 NBN ODF2 UBN2 YWHAB PBRM1 DST NUFIP2 CNOT1 PCM1 | 1.56e-05 | 645 | 143 | 12 | 25281560 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 30456986 | ||
| Pubmed | Regulation of microtubule-associated protein 1B (MAP1B) subunit composition. | 1.68e-05 | 2 | 143 | 2 | 11002287 | |
| Pubmed | Melanopsin-derived visual responses under light adapted conditions in the mouse dLGN. | 1.68e-05 | 2 | 143 | 2 | 25822371 | |
| Pubmed | Microtubule stability, Golgi organization, and transport flux require dystonin-a2-MAP1B interaction. | 1.68e-05 | 2 | 143 | 2 | 22412020 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 16996626 | ||
| Pubmed | Targeting the hepatocyte growth factor/c-Met signaling pathway in renal cell carcinoma. | 1.68e-05 | 2 | 143 | 2 | 23867513 | |
| Pubmed | The mouse and rat MAP1B genes: genomic organization and alternative transcription. | 1.68e-05 | 2 | 143 | 2 | 9615228 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 32790785 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 9199175 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 19851499 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 7806212 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 18275062 | ||
| Pubmed | Neuronal abnormalities in microtubule-associated protein 1B mutant mice. | 1.68e-05 | 2 | 143 | 2 | 8577753 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 2355215 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 7851898 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 19709076 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 34674288 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 22706862 | ||
| Pubmed | FRAS1 OGT TTC28 MAP1B RALGAPB ANKHD1 DST ZC3H4 UGGT2 PLCB3 EXOC7 RPL5 | 1.69e-05 | 650 | 143 | 12 | 38777146 | |
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 1.71e-05 | 130 | 143 | 6 | 35545047 | |
| Pubmed | Signaling pathways triggered by HIV-1 Tat in human monocytes to induce TNF-alpha. | 1.81e-05 | 38 | 143 | 4 | 12482669 | |
| Pubmed | 1.89e-05 | 13 | 143 | 3 | 37070251 | ||
| Pubmed | 1.89e-05 | 13 | 143 | 3 | 9670011 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | OGT MARS1 CARMIL1 UBR4 TACC2 FNBP1L ANKHD1 YWHAB SLC1A3 DHX8 RBM22 SF3B3 ZC3H4 PLCB3 TRMT1L PLEC RPL5 XPOT | 2.17e-05 | 1415 | 143 | 18 | 28515276 |
| Pubmed | Temporal patterning of apical progenitors and their daughter neurons in the developing neocortex. | 2.32e-05 | 82 | 143 | 5 | 31073041 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | OGT CENPE CENPF CARMIL1 TACC2 TASOR2 SERPINA1 PBRM1 SF3B3 PLAA ZC3H4 MKI67 MAIP1 CNOT1 VPS13B PCM1 | 2.32e-05 | 1155 | 143 | 16 | 20360068 |
| Pubmed | OGT TCF20 DNAH10 MARS1 UBR4 NBN ANKHD1 UBN2 PBRM1 DST RESF1 HGS MKI67 N4BP1 TRMT1L CNOT1 PCM1 XPOT | 2.47e-05 | 1429 | 143 | 18 | 35140242 | |
| Pubmed | 2.52e-05 | 285 | 143 | 8 | 32838362 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | ABCC3 NRG1 ANK2 CARMIL1 PARP14 SLC1A3 MET PTPRM PLCB1 PLCB3 VPS13B | 2.52e-05 | 569 | 143 | 11 | 30639242 |
| Pubmed | MYCBP2 MARS1 UBR4 ANKHD1 YWHAB P3H4 GSK3A MET DST HGS NUFIP2 MKI67 UGGT2 TRMT1L CNOT1 PCM1 XPOT | 2.57e-05 | 1297 | 143 | 17 | 33545068 | |
| Pubmed | 2.61e-05 | 469 | 143 | 10 | 27634302 | ||
| Pubmed | MYCBP2 CENPE MYO9B MARS1 UBR4 PARP14 YWHAB ITPR3 MGAT2 NUFIP2 MKI67 CD58 EXOC7 CNOT1 RPL5 PCM1 | 2.66e-05 | 1168 | 143 | 16 | 19946888 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 2.91e-05 | 475 | 143 | 10 | 31040226 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | MAP1A MAP1B CENPF UBR4 GRIK5 ANKHD1 DHX8 TIAL1 MAIP1 EIF4G3 CNOT1 RPL5 | 3.67e-05 | 704 | 143 | 12 | 29955894 |
| Interaction | FBXO22 interactions | CUL1 NRG1 COL6A6 CENPE CENPF MARS1 CARMIL1 TOGARAM2 NBEA SPG11 AK9 NEB TTC6 TTC19 SERPINA1 TIAL1 ZC3H4 CNOT1 XPOT | 7.57e-09 | 540 | 141 | 19 | int:FBXO22 |
| Interaction | CENPE interactions | 7.96e-07 | 106 | 141 | 8 | int:CENPE | |
| Interaction | SIRT7 interactions | TCF20 MAP1B MYCBP2 CENPF UBR4 ANKHD1 TASOR2 DHX8 ITPR3 PBRM1 DST NUFIP2 MKI67 PLEC EIF4G3 CNOT1 RPL5 PCM1 XPOT | 1.10e-06 | 744 | 141 | 19 | int:SIRT7 |
| Interaction | FMR1 interactions | THOC1 TCF20 MAP1B MYCBP2 UBR4 NBEA TACC2 GSK3A PBRM1 TIAL1 NUFIP2 MKI67 BSN CNOT1 RPL5 PCM1 | 1.13e-06 | 536 | 141 | 16 | int:FMR1 |
| Interaction | NAA40 interactions | SYNRG EED ANK2 NEBL MAP1A MAP1B MARS1 CARMIL1 NBN TACC2 ANKHD1 MOB3A YWHAB DST ZC3H4 NUFIP2 MKI67 EIF4G3 SCIN RPL5 PCM1 XPOT | 1.20e-06 | 978 | 141 | 22 | int:NAA40 |
| Interaction | PFN1 interactions | THOC1 SYNRG EED ANK2 MAP1A MYO9B CARMIL1 ITSN1 RALGAPB NBN NBEA ANKHD1 UGGT2 SCIN CNOT1 | 2.92e-06 | 509 | 141 | 15 | int:PFN1 |
| Interaction | PPIA interactions | CUL1 EED TCF20 NEBL MAP1A MAP1B CENPF ITSN1 NBN PTCH1 YWHAB DHX8 RBM22 DST ZC3H4 HGS ERRFI1 MKI67 TRMT1L | 1.41e-05 | 888 | 141 | 19 | int:PPIA |
| Interaction | FBXO42 interactions | 1.46e-05 | 259 | 141 | 10 | int:FBXO42 | |
| Interaction | RGS12 interactions | 1.52e-05 | 45 | 141 | 5 | int:RGS12 | |
| Interaction | MED4 interactions | THOC1 TTC28 MAP1B MYCBP2 CENPE ITSN1 NBN ODF2 DST HGS NUFIP2 CNOT1 PCM1 | 1.71e-05 | 450 | 141 | 13 | int:MED4 |
| Interaction | HECTD1 interactions | THOC1 EED TTC28 MAP1B MYCBP2 CENPE CENPF MYO9B TACC2 YWHAB GSK3A DHX8 PBRM1 NUFIP2 MKI67 TRMT1L EIF4G3 EXOC7 CNOT1 RPL5 | 1.72e-05 | 984 | 141 | 20 | int:HECTD1 |
| Interaction | OBSL1 interactions | THOC1 TCF20 CENPF RSPH6A TASOR2 DHX8 ITPR3 PBRM1 SF3B3 DST TIAL1 SEMA5B ZC3H4 MKI67 TRMT1L PLEC SCIN RPL5 PCM1 | 1.75e-05 | 902 | 141 | 19 | int:OBSL1 |
| Interaction | PHF21A interactions | OGT TTC28 MYCBP2 CENPF UBR4 ANKHD1 DST RESF1 BRCA2 PLEC PCM1 | 3.04e-05 | 343 | 141 | 11 | int:PHF21A |
| Interaction | NUP43 interactions | TCF20 CCDC168 UBN2 TASOR2 DHX8 FSIP2 PBRM1 DST RESF1 BRCA2 MKI67 TRMT1L EIF4G3 CNOT1 RPL5 | 3.32e-05 | 625 | 141 | 15 | int:NUP43 |
| Interaction | WWTR1 interactions | CUL1 SYNRG OGT TCF20 TTC28 MAP1B MYCBP2 NBN ANKHD1 YWHAB CNOT1 PCM1 | 4.25e-05 | 422 | 141 | 12 | int:WWTR1 |
| Interaction | SHANK3 interactions | SGIP1 TCF20 ANK2 MAP1A MAP1B ITSN1 YWHAB TASOR2 HGS PLCB1 EIF4G3 EXOC7 RPL5 | 4.68e-05 | 496 | 141 | 13 | int:SHANK3 |
| Interaction | SLX4 interactions | OGT TCF20 NBN ODF2 ANKHD1 UBN2 GSK3A RBM22 SERPINA1 SF3B3 RESF1 BRCA2 NUFIP2 MKI67 | 4.98e-05 | 572 | 141 | 14 | int:SLX4 |
| Interaction | EIF4ENIF1 interactions | 5.10e-05 | 300 | 141 | 10 | int:EIF4ENIF1 | |
| Interaction | ACTA1 interactions | CUL1 MAP1A MYO9B ITSN1 RSPH6A DST ERRFI1 PLEC POTEJ SCIN XPOT | 6.17e-05 | 371 | 141 | 11 | int:ACTA1 |
| Interaction | SYNGAP1 interactions | SGIP1 ANK2 MAP1A MAP1B MYCBP2 PDE6B GRIA1 NBEA SLC1A3 EIF4G3 | 6.19e-05 | 307 | 141 | 10 | int:SYNGAP1 |
| Interaction | MYO9A interactions | 7.74e-05 | 101 | 141 | 6 | int:MYO9A | |
| Interaction | TRPC3 interactions | 8.02e-05 | 33 | 141 | 4 | int:TRPC3 | |
| Interaction | BAP1 interactions | OGT MAP1B MYCBP2 MYO9B MARS1 UBR4 NBN ANKHD1 YWHAB PGM1 ITPR3 SF3B3 DST BRCA2 ZC3H4 NUFIP2 TRMT1L PLEC EIF4G3 EXOC7 CNOT1 RPL5 | 1.18e-04 | 1314 | 141 | 22 | int:BAP1 |
| Interaction | HSP90AB1 interactions | USP50 CUL1 EED OGT MAP1B MYCBP2 CENPF MTF2 MYO9B UBR4 SPG11 ODF2 NEB YWHAB GSK3A MET BRCA2 RPL5 | 1.31e-04 | 960 | 141 | 18 | int:HSP90AB1 |
| Interaction | NR3C1 interactions | ABCC3 FAT4 TCF20 TTC28 UBR4 NBN NBEA NEB SLC1A3 DNAH7 ITPR3 RBM22 PBRM1 PLCB1 MAIP1 POTEJ BSN CNOT1 | 1.57e-04 | 974 | 141 | 18 | int:NR3C1 |
| Interaction | MYPN interactions | 1.73e-04 | 40 | 141 | 4 | int:MYPN | |
| Interaction | MAP1A interactions | 1.74e-04 | 117 | 141 | 6 | int:MAP1A | |
| Interaction | ABI1 interactions | 1.78e-04 | 223 | 141 | 8 | int:ABI1 | |
| Cytoband | 1p22.1 | 1.37e-04 | 32 | 143 | 3 | 1p22.1 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 1.13e-04 | 19 | 91 | 3 | 832 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 2.87e-04 | 115 | 91 | 5 | 769 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily G | 5.18e-04 | 7 | 91 | 2 | 917 | |
| GeneFamily | EF-hand domain containing|Plakins | 6.88e-04 | 8 | 91 | 2 | 939 | |
| GeneFamily | Phospholipases | 1.23e-03 | 42 | 91 | 3 | 467 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.21e-03 | 181 | 91 | 5 | 694 | |
| GeneFamily | Dyneins, axonemal | 3.24e-03 | 17 | 91 | 2 | 536 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CUL1 NRG1 OGT TTC28 MAP1B MYCBP2 CENPE CENPF MTF2 MYO9B ITSN1 NBN SPG11 FNBP1L SLIT2 DST BRCA2 PTPRM ZC3H4 N4BP1 EIF4G3 VPS13B | 1.58e-09 | 856 | 143 | 22 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | CUL1 NRG1 OGT MAP1B MYCBP2 CENPE CENPF MTF2 ITSN1 NBN FNBP1L DST ZC3H4 EIF4G3 | 2.86e-07 | 466 | 143 | 14 | M13522 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | SYNRG OGT OSTM1 MYCBP2 MYO9B UBR4 RALGAPB SPG11 PARP14 MOB3A YWHAB EPG5 LRRN3 SF3B3 RESF1 TIAL1 NUFIP2 PLCB2 N4BP1 PRKCQ CNOT1 RPL5 VPS13B PCM1 | 1.78e-06 | 1492 | 143 | 24 | M40023 |
| Coexpression | GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN | 1.42e-05 | 199 | 143 | 8 | M6060 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | NEBL OSTM1 MAP1A MAP1B MYCBP2 NBEA PTCH1 RRAGC ITPR3 DST ABCA5 ERRFI1 PLCB1 EIF4G3 RPL5 PCM1 XPOT | 1.66e-05 | 946 | 143 | 17 | M39169 |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 3.01e-05 | 221 | 143 | 8 | M39222 | |
| Coexpression | BLANCO_MELO_SARS_COV_1_INFECTION_MCR5_CELLS_UP | 3.37e-05 | 12 | 143 | 3 | M34000 | |
| Coexpression | LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB | 4.10e-05 | 169 | 143 | 7 | M39230 | |
| Coexpression | GAO_ESOPHAGUS_25W_C1_CILIATED_EPITHELIAL_CELLS | DNAH10 RIBC2 TOGARAM2 ARHGEF38 NBEA AK9 DNAH7 DYDC2 PTPRT PLCB2 CFAP46 | 4.58e-05 | 459 | 143 | 11 | M39136 |
| Coexpression | LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES | 4.88e-05 | 37 | 143 | 4 | M1726 | |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 5.30e-05 | 176 | 143 | 7 | M39223 | |
| Coexpression | GENTILE_UV_RESPONSE_CLUSTER_D2 | 5.43e-05 | 38 | 143 | 4 | M12861 | |
| Coexpression | LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES | 6.02e-05 | 39 | 143 | 4 | MM722 | |
| Coexpression | DELPUECH_FOXO3_TARGETS_DN | 6.66e-05 | 40 | 143 | 4 | M2314 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN | 1.04e-04 | 85 | 143 | 5 | M10575 | |
| Coexpression | GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_6H_UP | 1.08e-04 | 197 | 143 | 7 | M8159 | |
| Coexpression | GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_DN | 1.14e-04 | 199 | 143 | 7 | M7099 | |
| Coexpression | GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_DN | 1.14e-04 | 199 | 143 | 7 | M4977 | |
| Coexpression | GSE23695_CD57_POS_VS_NEG_NK_CELL_UP | 1.14e-04 | 199 | 143 | 7 | M7784 | |
| Coexpression | GSE2585_CTEC_VS_THYMIC_MACROPHAGE_DN | 1.14e-04 | 199 | 143 | 7 | M6264 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 1.14e-04 | 199 | 143 | 7 | M5893 | |
| Coexpression | HALLMARK_G2M_CHECKPOINT | 1.18e-04 | 200 | 143 | 7 | M5901 | |
| Coexpression | GRUETZMANN_PANCREATIC_CANCER_UP | 1.64e-04 | 359 | 143 | 9 | M15193 | |
| Coexpression | GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_UP | 1.66e-04 | 148 | 143 | 6 | M1892 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | CENPE CENPF RALGAPB NBN ANKHD1 RESF1 BRCA2 PLCB1 CD58 UGGT2 PLEC CNOT1 XPOT | 1.67e-04 | 721 | 143 | 13 | M10237 |
| Coexpression | IBRAHIM_NRF2_UP | CUL1 NRG1 MAP1A MARS1 NBN ZBTB41 YWHAB MSANTD3 PLAA NUFIP2 XPOT | 1.71e-04 | 533 | 143 | 11 | M42510 |
| Coexpression | GSE7568_IL4_VS_IL4_AND_DEXAMETHASONE_TREATED_MACROPHAGE_DN | 1.85e-04 | 151 | 143 | 6 | M369 | |
| Coexpression | LAKE_ADULT_KIDNEY_C24_ENDOTHELIAL_CELLS_AEA_AND_DVR | 1.91e-04 | 152 | 143 | 6 | M39243 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.18e-09 | 157 | 143 | 9 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.21e-08 | 191 | 143 | 9 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.21e-08 | 191 | 143 | 9 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.27e-08 | 192 | 143 | 9 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-08 | 197 | 143 | 9 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | Control_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type | DNAH10 RIBC2 TOGARAM2 ARHGEF38 DNAH7 TTC6 BMP3 SERPINA1 SCIN | 1.65e-08 | 198 | 143 | 9 | e6863238e022ecfb6a8e3f4b7661b376e92c5d8f |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type | DNAH10 RIBC2 TOGARAM2 ARHGEF38 DNAH7 TTC6 BMP3 SERPINA1 SCIN | 1.65e-08 | 198 | 143 | 9 | e7aa42e5fbd42c68f50cda4a8f3aa464c862c007 |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | DNAH10 RIBC2 TOGARAM2 ARHGEF38 DNAH7 DYDC2 TTC6 SERPINA1 SCIN | 1.80e-08 | 200 | 143 | 9 | da12821e8a0657869ca0f75d351cce2d7605a505 |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.80e-08 | 200 | 143 | 9 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | DNAH10 RIBC2 TOGARAM2 ARHGEF38 DNAH7 DYDC2 TTC6 SERPINA1 SCIN | 1.80e-08 | 200 | 143 | 9 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.75e-08 | 169 | 143 | 8 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.62e-07 | 186 | 143 | 8 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | Ciliated_cells-B-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.76e-07 | 188 | 143 | 8 | 606907c865bd2f11bb6474932716550f7723d858 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-07 | 190 | 143 | 8 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | Epithelial_cells-Ciliated_cells-B|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.91e-07 | 190 | 143 | 8 | 426a4806f6e39d4d57c6746609d30bb3ca62df7d | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.98e-07 | 191 | 143 | 8 | 683e5c7e6173644f01e67c98ab7b75d7cb9cce99 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.07e-07 | 192 | 143 | 8 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.07e-07 | 192 | 143 | 8 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-07 | 193 | 143 | 8 | 263d185af6ed80e639f864e4966268e0862c61dc | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-07 | 193 | 143 | 8 | 80e058c224749b5fe0ba3e944b48317c2371cb63 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-07 | 193 | 143 | 8 | b991fbbb4618401624f0b3045f0e81a606d3a763 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 2.15e-07 | 193 | 143 | 8 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-07 | 194 | 143 | 8 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.24e-07 | 194 | 143 | 8 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.24e-07 | 194 | 143 | 8 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.24e-07 | 194 | 143 | 8 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 2.32e-07 | 195 | 143 | 8 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.32e-07 | 195 | 143 | 8 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 2.32e-07 | 195 | 143 | 8 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 2.32e-07 | 195 | 143 | 8 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 2.32e-07 | 195 | 143 | 8 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-07 | 195 | 143 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 2.42e-07 | 196 | 143 | 8 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 2.42e-07 | 196 | 143 | 8 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 2.42e-07 | 196 | 143 | 8 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 2.42e-07 | 196 | 143 | 8 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 2.42e-07 | 196 | 143 | 8 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.51e-07 | 197 | 143 | 8 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.51e-07 | 197 | 143 | 8 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.61e-07 | 198 | 143 | 8 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.82e-07 | 200 | 143 | 8 | bad32a95b759fad509401b07bc96a56687c2a592 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.20e-07 | 148 | 143 | 7 | d61123f0c811287843d066b932b4a9ff09c07c5b | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.20e-07 | 148 | 143 | 7 | c8e93b87212f55774223caa385859c566fa1981f | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.80e-07 | 154 | 143 | 7 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.80e-07 | 154 | 143 | 7 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.41e-07 | 156 | 143 | 7 | 7569cab30caafcb273e8ef0b73c9e1bf87076984 | |
| ToppCell | Control-Epithelial_airway|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.08e-07 | 158 | 143 | 7 | 35aee1c3b92169e73569331022833cb44ab7e7e8 | |
| ToppCell | LPS-antiTNF-Epithelial_airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.12e-06 | 166 | 143 | 7 | eb942ed68677e55c46cb039046f45686d4062d7c | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.27e-06 | 169 | 143 | 7 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | Ciliated_cells-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.79e-06 | 178 | 143 | 7 | 255473ee6df8a13079fb3bb61038162a40cb4c2c | |
| ToppCell | Ciliated_cells-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.86e-06 | 179 | 143 | 7 | 0e6c22de2e3fb0ff23b3301863cf4011c5c59dff | |
| ToppCell | (05)_Ciliated-(4)_1wkpi|(05)_Ciliated / shred by cell type and Timepoint | 1.93e-06 | 180 | 143 | 7 | 85fc9b164147b28545e2397d32302eea03ef6346 | |
| ToppCell | Ciliated_cells-A-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.93e-06 | 180 | 143 | 7 | d9be152773fe9f2160edad9246fa03c03afeafd6 | |
| ToppCell | Ciliated_cells-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 2.08e-06 | 182 | 143 | 7 | e93968f800bfeb258e4e834fc8bf92d1cb72cd73 | |
| ToppCell | Ciliated_cells-B-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.49e-06 | 187 | 143 | 7 | 2b4262c2e7c7830a976be168cee6eeb738d4feda | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 2.49e-06 | 187 | 143 | 7 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.49e-06 | 187 | 143 | 7 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.57e-06 | 188 | 143 | 7 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-06 | 189 | 143 | 7 | aadb7a2de4cbe7f0958651f2739bba430b93f5c1 | |
| ToppCell | Multiciliated|World / shred by cell class for nasal brushing | 2.67e-06 | 189 | 143 | 7 | 34b110aef839376228c5a403a6b5047a945f472b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-06 | 189 | 143 | 7 | 8977f3295b7df7c7474b3f371de90a82ae4bb50c | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 2.67e-06 | 189 | 143 | 7 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | Epithelial_cells-Ciliated_cells-A|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 2.76e-06 | 190 | 143 | 7 | 549d813a8f23b175875e53347928941f143e236c | |
| ToppCell | Ciliated_cells-B|World / lung cells shred on cell class, cell subclass, sample id | 2.76e-06 | 190 | 143 | 7 | 7031fbedc13be1a00f6333ad6d51849c3739c2e6 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.76e-06 | 190 | 143 | 7 | a90a38fccdbf75a286b4d258fc54920c02b282f7 | |
| ToppCell | Ciliated_cells-A|World / lung cells shred on cell class, cell subclass, sample id | 2.76e-06 | 190 | 143 | 7 | cd87731aaa7d252424f79cfce9f7931457f17bdf | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 2.76e-06 | 190 | 143 | 7 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.86e-06 | 191 | 143 | 7 | 5a67ff17fb4b9eff641176dff07830c9cd73754e | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.86e-06 | 191 | 143 | 7 | 54f07e4de61735051498846afb44b1798bed8144 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.86e-06 | 191 | 143 | 7 | 55ab2854a02cdcfc395e49870ccb7290b5e5471d | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.86e-06 | 191 | 143 | 7 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 2.96e-06 | 192 | 143 | 7 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 2.96e-06 | 192 | 143 | 7 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 2.96e-06 | 192 | 143 | 7 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 2.96e-06 | 192 | 143 | 7 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-06 | 193 | 143 | 7 | ca7c0a4ceb05bced90f6cdc53d278e547fb241e9 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 3.06e-06 | 193 | 143 | 7 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.06e-06 | 193 | 143 | 7 | 0b62a6ddd7c42efd9f39781971d1438501e1fa8d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.17e-06 | 194 | 143 | 7 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.17e-06 | 194 | 143 | 7 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.17e-06 | 194 | 143 | 7 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.28e-06 | 195 | 143 | 7 | 938b31dbf1674ee6fd0123bc88391ddcaf151217 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.28e-06 | 195 | 143 | 7 | 649fd2336e963f6a150d182a53ad5dd838ca80b1 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 3.28e-06 | 195 | 143 | 7 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.28e-06 | 195 | 143 | 7 | d39e9e6544f49e677ebe528c6fe60b99a3630e30 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-06 | 195 | 143 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.28e-06 | 195 | 143 | 7 | 129ad5f4253ecb1a8477cc38773e6e91ea9570b0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.28e-06 | 195 | 143 | 7 | 3e70ee987d66d450062d5df3d7c733ccc7344470 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-06 | 195 | 143 | 7 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | COVID-19-kidney-TAL|kidney / Disease (COVID-19 only), tissue and cell type | 3.39e-06 | 196 | 143 | 7 | 04f5eb206ed3016a737609a3ebac0c1fcabb94ef | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.39e-06 | 196 | 143 | 7 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.39e-06 | 196 | 143 | 7 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.51e-06 | 197 | 143 | 7 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.51e-06 | 197 | 143 | 7 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.51e-06 | 197 | 143 | 7 | 63b63c6b2f842adb87bc83222ff86796bd9b58f6 | |
| ToppCell | COVID-19-Epithelial|COVID-19 / Condition, Lineage and Cell class | 3.51e-06 | 197 | 143 | 7 | 18fd7344628a87d5c7ef5efb66e260a4136245bf | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.51e-06 | 197 | 143 | 7 | fb50903b87498b400c8e16e6a561b6d9458e5d97 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-G|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.51e-06 | 197 | 143 | 7 | a21a710c824f9e5c7ef1674168d1ce5aef85bd35 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.63e-06 | 198 | 143 | 7 | 6a539d3b47bd2d4a7ad5c67cad23facffc0ac45f | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 3.63e-06 | 198 | 143 | 7 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| Drug | 3-nitrocoumarin | 3.04e-07 | 10 | 143 | 4 | CID002799766 | |
| Drug | GW8510; Down 200; 10uM; MCF7; HT_HG-U133A | 2.43e-06 | 183 | 143 | 9 | 7062_DN | |
| Drug | aluminum | 2.54e-06 | 184 | 143 | 9 | CID000104727 | |
| Drug | C10A | 4.79e-06 | 6 | 143 | 3 | CID000041624 | |
| Drug | SKF83742 | 4.79e-06 | 6 | 143 | 3 | CID000130828 | |
| Drug | Alprenolol hydrochloride [13707-88-5]; Down 200; 14uM; MCF7; HT_HG-U133A | 5.03e-06 | 200 | 143 | 9 | 6789_DN | |
| Drug | papaverine | 1.59e-05 | 176 | 143 | 8 | CID000004680 | |
| Drug | Trifluridine [70-00-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 2.98e-05 | 192 | 143 | 8 | 7176_DN | |
| Drug | Monobenzone [103-16-2]; Down 200; 20uM; HL60; HT_HG-U133A | 2.98e-05 | 192 | 143 | 8 | 3054_DN | |
| Drug | Canrenoic acid potassium salt [2181-04-6]; Down 200; 10uM; MCF7; HT_HG-U133A | 3.09e-05 | 193 | 143 | 8 | 6783_DN | |
| Drug | Furazolidone [67-45-8]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 3.20e-05 | 194 | 143 | 8 | 4178_DN | |
| Drug | Hymecromone [90-33-5]; Up 200; 22.8uM; MCF7; HT_HG-U133A | 3.45e-05 | 196 | 143 | 8 | 3383_UP | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 3.45e-05 | 196 | 143 | 8 | 1024_DN | |
| Drug | novobiocin sodium, USP; Down 200; 100uM; ssMCF7; HG-U133A | 3.45e-05 | 196 | 143 | 8 | 499_DN | |
| Drug | Dobutamine hydrochloride [49745-95-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 3.45e-05 | 196 | 143 | 8 | 5386_DN | |
| Drug | Quinethazone [73-49-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 3.45e-05 | 196 | 143 | 8 | 3875_UP | |
| Drug | sulindac sulfide; Down 200; 50uM; MCF7; HG-U133A | 3.57e-05 | 197 | 143 | 8 | 308_DN | |
| Drug | Trimipramine maleate salt [521-78-8]; Down 200; 9.8uM; HL60; HT_HG-U133A | 3.57e-05 | 197 | 143 | 8 | 3004_DN | |
| Drug | N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; MCF7; HT_HG-U133A | 3.57e-05 | 197 | 143 | 8 | 3930_DN | |
| Drug | Lymecycline [992-21-2]; Up 200; 6.6uM; PC3; HT_HG-U133A | 3.70e-05 | 198 | 143 | 8 | 7291_UP | |
| Drug | catechin; Down 200; 11uM; MCF7; HT_HG-U133A_EA | 3.70e-05 | 198 | 143 | 8 | 1101_DN | |
| Drug | Chlorphensin carbamate [886-74-8]; Up 200; 16.2uM; HL60; HG-U133A | 3.84e-05 | 199 | 143 | 8 | 1432_UP | |
| Drug | Chrysin [480-40-0]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 3.84e-05 | 199 | 143 | 8 | 5505_UP | |
| Drug | Norethindrone [68-22-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 3.84e-05 | 199 | 143 | 8 | 7414_UP | |
| Drug | Cephalothin sodium salt [58-71-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 3.84e-05 | 199 | 143 | 8 | 6079_DN | |
| Drug | isopetasin | 3.86e-05 | 11 | 143 | 3 | CID005318627 | |
| Drug | 3 Cu | 3.92e-05 | 2 | 143 | 2 | CID009859098 | |
| Drug | Isocorydine (+) [475-67-2]; Down 200; 11.8uM; PC3; HT_HG-U133A | 3.98e-05 | 200 | 143 | 8 | 4505_DN | |
| Drug | Sulcrate | 4.25e-05 | 148 | 143 | 7 | CID006398525 | |
| Drug | AC1L1II7 | 5.12e-05 | 12 | 143 | 3 | CID000004589 | |
| Drug | norathyriol | 8.39e-05 | 37 | 143 | 4 | CID005281656 | |
| Drug | AC1MQNLW | 8.39e-05 | 14 | 143 | 3 | CID003504628 | |
| Drug | AC1L1E5T | 1.04e-04 | 74 | 143 | 5 | CID000002653 | |
| Drug | glutamate | CUL1 NRG1 NTF3 MARS1 GRIA1 GRIK5 SLC1A3 DHX8 ITPR3 SERPINA1 PLCB1 PLCB2 PLCB3 PRKCQ PLEC BSN MAPK10 | 1.16e-04 | 962 | 143 | 17 | CID000000611 |
| Drug | cloquintocet-mexyl | 1.17e-04 | 3 | 143 | 2 | CID000093528 | |
| Drug | dbdC | 1.17e-04 | 3 | 143 | 2 | CID000072684 | |
| Drug | AR-2 | 1.17e-04 | 3 | 143 | 2 | CID000023840 | |
| Drug | casuarine | 1.17e-04 | 3 | 143 | 2 | CID000384347 | |
| Drug | m-3M3FBS | 1.28e-04 | 16 | 143 | 3 | CID000761523 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 1.41e-04 | 179 | 143 | 7 | 1005_UP | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.72e-04 | 185 | 143 | 7 | 4755_DN | |
| Drug | Etoposide [33419-42-0]; Down 200; 6.8uM; MCF7; HT_HG-U133A | 1.72e-04 | 185 | 143 | 7 | 3241_DN | |
| Drug | GW8510; Down 200; 10uM; MCF7; HT_HG-U133A | 1.84e-04 | 187 | 143 | 7 | 7080_DN | |
| Drug | Ciclopirox ethanolamine [41621-49-2]; Down 200; 15uM; MCF7; HT_HG-U133A | 1.84e-04 | 187 | 143 | 7 | 5023_DN | |
| Drug | lithium aluminum hydride | 1.96e-04 | 320 | 143 | 9 | CID000028112 | |
| Drug | Methotrexate [59-05-2]; Down 200; 8.8uM; HL60; HG-U133A | 1.96e-04 | 189 | 143 | 7 | 2041_DN | |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | 2.10e-04 | 191 | 143 | 7 | 4168_DN | |
| Drug | sapintoxin A | 2.18e-04 | 19 | 143 | 3 | CID000108085 | |
| Drug | Gabapentin [60142-96-3]; Up 200; 23.4uM; MCF7; HT_HG-U133A | 2.23e-04 | 193 | 143 | 7 | 7229_UP | |
| Drug | 0316684-0000 [391209-55-5]; Up 200; 10uM; PC3; HT_HG-U133A | 2.23e-04 | 193 | 143 | 7 | 7098_UP | |
| Drug | CP-863187 [668981-07-5]; Down 200; 10uM; PC3; HT_HG-U133A | 2.30e-04 | 194 | 143 | 7 | 7558_DN | |
| Drug | Moricizine hydrochloride [31883-05-3]; Up 200; 8.6uM; HL60; HT_HG-U133A | 2.30e-04 | 194 | 143 | 7 | 2959_UP | |
| Drug | nimbidiol | 2.33e-04 | 4 | 143 | 2 | ctd:C496111 | |
| Drug | phytenic acid | 2.33e-04 | 4 | 143 | 2 | CID005282676 | |
| Drug | avermectin | 2.34e-04 | 48 | 143 | 4 | CID006450460 | |
| Drug | Xylazine [7361-61-7]; Up 200; 18.2uM; HL60; HT_HG-U133A | 2.38e-04 | 195 | 143 | 7 | 2132_UP | |
| Drug | Thioperamide maleate [106243-16-7]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 2.38e-04 | 195 | 143 | 7 | 3392_DN | |
| Drug | Carbimazole [22232-54-8]; Down 200; 21.4uM; MCF7; HT_HG-U133A | 2.38e-04 | 195 | 143 | 7 | 5399_DN | |
| Drug | Ebselen [60940-34-3]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 2.38e-04 | 195 | 143 | 7 | 3458_DN | |
| Drug | quercetin dihydrate; Up 200; 1uM; MCF7; HG-U133A | 2.45e-04 | 196 | 143 | 7 | 283_UP | |
| Drug | Terconazole [67915-31-5]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 2.45e-04 | 196 | 143 | 7 | 2844_DN | |
| Drug | copper(II) sulfate pentahydrate; Down 200; 100uM; ssMCF7; HG-U133A | 2.45e-04 | 196 | 143 | 7 | 500_DN | |
| Drug | ICI 182,780; Up 200; 1uM; MCF7; HT_HG-U133A | 2.53e-04 | 197 | 143 | 7 | 5565_UP | |
| Drug | haloperidol; Up 200; 10uM; HL60; HT_HG-U133A | 2.53e-04 | 197 | 143 | 7 | 6203_UP | |
| Drug | Aconitine [302-27-2]; Down 200; 6.2uM; MCF7; HT_HG-U133A | 2.53e-04 | 197 | 143 | 7 | 6797_DN | |
| Drug | Cytisine (-) [485-35-8]; Up 200; 21uM; MCF7; HT_HG-U133A | 2.53e-04 | 197 | 143 | 7 | 2759_UP | |
| Drug | Trolox [53188-07-1]; Up 200; 16uM; PC3; HT_HG-U133A | 2.53e-04 | 197 | 143 | 7 | 7304_UP | |
| Drug | Nabumetone [42924-53-8]; Down 200; 17.6uM; MCF7; HT_HG-U133A | 2.53e-04 | 197 | 143 | 7 | 6487_DN | |
| Drug | Gelsemine [509-15-9]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 2.53e-04 | 197 | 143 | 7 | 4177_DN | |
| Drug | nordihydroguaiaretic acid; Up 200; 1uM; MCF7; HG-U133A | 2.53e-04 | 197 | 143 | 7 | 203_UP | |
| Drug | Benzylpenicillin sodium [69-57-8]; Down 200; 11.2uM; PC3; HT_HG-U133A | 2.53e-04 | 197 | 143 | 7 | 4501_DN | |
| Drug | Clindamycin hydrochloride [21462-39-5]; Down 200; 8.6uM; PC3; HT_HG-U133A | 2.53e-04 | 197 | 143 | 7 | 5815_DN | |
| Drug | Pyrilamine maleate [59-33-6]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.53e-04 | 197 | 143 | 7 | 3184_UP | |
| Drug | 0225151-0000 [351320-15-5]; Up 200; 10uM; PC3; HT_HG-U133A | 2.53e-04 | 197 | 143 | 7 | 6389_UP | |
| Drug | dicyclohexyl phthalate | ABCC3 MGAM EED ANK2 MAP1B CENPF GRIA1 SLC1A3 PGM1 ABCB4 ITPR3 PBRM1 HPGDS PRKCQ CNOT1 | 2.55e-04 | 836 | 143 | 15 | ctd:C036042 |
| Drug | AC1N8N2J | 2.56e-04 | 20 | 143 | 3 | CID004346372 | |
| Drug | NSC99363 | 2.61e-04 | 90 | 143 | 5 | CID000414014 | |
| Drug | genistein; Down 200; 10uM; MCF7; HG-U133A | 2.61e-04 | 198 | 143 | 7 | 382_DN | |
| Drug | N-phenylanthranilic acid; Up 200; 10uM; MCF7; HG-U133A | 2.61e-04 | 198 | 143 | 7 | 317_UP | |
| Drug | Delcorine; Up 200; 8.4uM; HL60; HT_HG-U133A | 2.61e-04 | 198 | 143 | 7 | 2178_UP | |
| Drug | Myricetin [529-44-2]; Down 200; 12.6uM; PC3; HT_HG-U133A | 2.61e-04 | 198 | 143 | 7 | 4090_DN | |
| Drug | Cefotiam hydrochloride; Up 200; 7.2uM; MCF7; HT_HG-U133A | 2.61e-04 | 198 | 143 | 7 | 5361_UP | |
| Drug | Amoxicillin [26787-78-0]; Up 200; 11uM; HL60; HT_HG-U133A | 2.61e-04 | 198 | 143 | 7 | 1265_UP | |
| Drug | Dicumarol [66-76-2]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.61e-04 | 198 | 143 | 7 | 3941_UP | |
| Drug | Oxantel pamoate [68813-55-8]; Down 200; 6.6uM; PC3; HT_HG-U133A | 2.61e-04 | 198 | 143 | 7 | 6738_DN | |
| Drug | Scopolamine hydrochloride [55-16-3]; Down 200; 11.8uM; HL60; HT_HG-U133A | 2.61e-04 | 198 | 143 | 7 | 3018_DN | |
| Drug | Betulinic acid [472-15-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 2.61e-04 | 198 | 143 | 7 | 3281_DN | |
| Drug | Nifurtimox [23256-30-6]; Down 200; 14uM; MCF7; HT_HG-U133A | 2.61e-04 | 198 | 143 | 7 | 7328_DN | |
| Drug | Cefamandole sodium salt [30034-03-8]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 2.61e-04 | 198 | 143 | 7 | 3436_UP | |
| Drug | Felbinac [5728-52-9]; Up 200; 18.8uM; HL60; HT_HG-U133A | 2.69e-04 | 199 | 143 | 7 | 3061_UP | |
| Drug | clofibrate; Up 200; 100uM; MCF7; HG-U133A | 2.69e-04 | 199 | 143 | 7 | 444_UP | |
| Drug | Dinoprost trometamol [38362-01-5]; Down 200; 8.4uM; PC3; HT_HG-U133A | 2.69e-04 | 199 | 143 | 7 | 6308_DN | |
| Drug | 5149715; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 2.69e-04 | 199 | 143 | 7 | 890_UP | |
| Drug | Ascorbic acid [50-81-7]; Down 200; 22.4uM; MCF7; HT_HG-U133A | 2.69e-04 | 199 | 143 | 7 | 5407_DN | |
| Disease | glucose measurement | SGIP1 MYCBP2 ENTHD1 FNBP1L YWHAB ITPR3 PHYH ZC3H4 NUFIP2 BSN | 1.36e-05 | 380 | 139 | 10 | EFO_0004468 |
| Disease | Alzheimer disease, polygenic risk score | FRAS1 TCF20 GRIA1 SPG11 TACC2 RSPH6A FSIP2 SF3B3 DST RESF1 EIF4G3 SCIN | 2.27e-05 | 586 | 139 | 12 | EFO_0030082, MONDO_0004975 |
| Disease | pulse pressure measurement | USP50 TDRD15 NRG1 SGIP1 ANK2 NEBL TTC28 MAP1B CARMIL1 NBEA ZBTB41 ODF2 DYDC2 P3H4 DHX8 MET PBRM1 CNOT1 PCM1 | 3.02e-05 | 1392 | 139 | 19 | EFO_0005763 |
| Disease | Malignant neoplasm of breast | NRG1 CATSPERE ANK2 RIBC2 CENPF UBR4 ARHGEF38 NBN TACC2 EPG5 PBRM1 BRCA2 SEMA5B MKI67 PLCB1 VPS13B | 4.85e-05 | 1074 | 139 | 16 | C0006142 |
| Disease | carbohydrate measurement | 6.60e-05 | 46 | 139 | 4 | EFO_0004998 | |
| Disease | Schizophrenia | NRG1 MYO9B NTF3 GRIA1 GRIK5 SLC1A3 GSK3A MET PBRM1 PLAA HPGDS NUFIP2 PLCB1 PCM1 | 7.69e-05 | 883 | 139 | 14 | C0036341 |
| Disease | Tourette syndrome, schizophrenia | 7.93e-05 | 18 | 139 | 3 | EFO_0004895, MONDO_0005090 | |
| Disease | Bipolar Disorder | NRG1 GRIA1 GRIK5 SLC1A3 GSK3A SERPINA1 PBRM1 BRCA2 HPGDS PLCB1 | 9.23e-05 | 477 | 139 | 10 | C0005586 |
| Disease | pancreatic cancer (is_marker_for) | 1.19e-04 | 101 | 139 | 5 | DOID:1793 (is_marker_for) | |
| Disease | Episodic Ataxia | 1.31e-04 | 4 | 139 | 2 | C1720189 | |
| Disease | non-high density lipoprotein cholesterol measurement | TDRD15 DNAH10 CARMIL1 GRIK5 P3H4 ABCB4 SERPINA1 PBRM1 BRCA2 ZC3H4 NUFIP2 BAIAP2L2 | 1.47e-04 | 713 | 139 | 12 | EFO_0005689 |
| Disease | FEV/FEC ratio | MGAM FRAS1 NEBL ARHGEF38 RSPH6A PTCH1 NEB SLC1A3 MET SERPINA1 DST PTPRM UGGT2 MAIP1 MAPK10 RPL5 | 2.27e-04 | 1228 | 139 | 16 | EFO_0004713 |
| Disease | Prostate cancer, familial | 3.22e-04 | 69 | 139 | 4 | C2931456 | |
| Disease | intellectual disability (implicated_via_orthology) | 4.42e-04 | 75 | 139 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | epidermolysis bullosa simplex (is_implicated_in) | 4.56e-04 | 7 | 139 | 2 | DOID:4644 (is_implicated_in) | |
| Disease | obesity (implicated_via_orthology) | 5.61e-04 | 215 | 139 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | right ventricular systolic volume measurement | 6.00e-04 | 35 | 139 | 3 | EFO_0021815 | |
| Disease | holoprosencephaly (is_implicated_in) | 6.06e-04 | 8 | 139 | 2 | DOID:4621 (is_implicated_in) | |
| Disease | disease recurrence, malaria | 6.06e-04 | 8 | 139 | 2 | EFO_0001068, EFO_0004952 | |
| Disease | emphysema imaging measurement | 6.54e-04 | 146 | 139 | 5 | EFO_0007626 | |
| Disease | Liver carcinoma | 6.94e-04 | 507 | 139 | 9 | C2239176 | |
| Disease | Inherited neuropathies | 8.90e-04 | 40 | 139 | 3 | C0598589 | |
| Disease | celiac disease (is_implicated_in) | 9.67e-04 | 10 | 139 | 2 | DOID:10608 (is_implicated_in) | |
| Disease | creativity measurement | 9.67e-04 | 10 | 139 | 2 | EFO_0010650 | |
| Disease | asthma exacerbation measurement | 9.95e-04 | 93 | 139 | 4 | EFO_0007614 | |
| Disease | autosomal dominant nonsyndromic deafness (is_implicated_in) | 1.18e-03 | 11 | 139 | 2 | DOID:0050564 (is_implicated_in) | |
| Disease | Copper-Overload Cirrhosis | 1.18e-03 | 11 | 139 | 2 | C1876165 | |
| Disease | Malignant neoplasm of kidney | 1.26e-03 | 45 | 139 | 3 | C0740457 | |
| Disease | visceral:gluteofemoral adipose tissue ratio measurement | 1.26e-03 | 45 | 139 | 3 | EFO_0803319 | |
| Disease | Charcot-Marie-Tooth disease (is_implicated_in) | 1.41e-03 | 12 | 139 | 2 | DOID:10595 (is_implicated_in) | |
| Disease | fructose measurement | 1.66e-03 | 13 | 139 | 2 | EFO_0010477 | |
| Disease | Medulloblastoma | 1.71e-03 | 50 | 139 | 3 | C0025149 | |
| Disease | cerebellum cortex volume change measurement | 1.93e-03 | 14 | 139 | 2 | EFO_0021497 | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 1.93e-03 | 14 | 139 | 2 | C0677776 | |
| Disease | stroke outcome severity measurement | 2.11e-03 | 114 | 139 | 4 | EFO_0009603 | |
| Disease | Rhabdomyosarcoma | 2.22e-03 | 15 | 139 | 2 | C0035412 | |
| Disease | Carcinoma, Granular Cell | 2.25e-03 | 116 | 139 | 4 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 2.25e-03 | 116 | 139 | 4 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 2.25e-03 | 116 | 139 | 4 | C0205642 | |
| Disease | Carcinoma, Cribriform | 2.25e-03 | 116 | 139 | 4 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 2.25e-03 | 116 | 139 | 4 | C0205641 | |
| Disease | Adenocarcinoma | 2.25e-03 | 116 | 139 | 4 | C0001418 | |
| Disease | Intrahepatic cholestasis of pregnancy | 2.53e-03 | 16 | 139 | 2 | EFO_0009048 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 2.63e-03 | 200 | 139 | 5 | EFO_0004611, EFO_0020945 | |
| Disease | eicosapentaenoate EPA; 20:5n3 measurement | 2.86e-03 | 17 | 139 | 2 | EFO_0021049 | |
| Disease | red blood cell density measurement | NRG1 DNAH10 ITSN1 FNBP1L PBRM1 DST ZC3H4 PLCB3 PLEC EIF4G3 VPS13B | 3.07e-03 | 880 | 139 | 11 | EFO_0007978 |
| Disease | alkaline phosphatase measurement | TDRD15 MAP1A CARMIL1 GRIK5 FNBP1L PTCH1 SLC1A3 SERPINA1 TREH NUFIP2 EIF4G3 CNOT1 | 3.15e-03 | 1015 | 139 | 12 | EFO_0004533 |
| Disease | Disorder of eye | 3.37e-03 | 212 | 139 | 5 | C0015397 | |
| Disease | Chronic myeloproliferative disorder | 3.57e-03 | 19 | 139 | 2 | C1292778 | |
| Disease | Central precocious puberty | 3.57e-03 | 19 | 139 | 2 | EFO_0009029 | |
| Disease | colorectal cancer, inflammatory bowel disease | 3.57e-03 | 19 | 139 | 2 | EFO_0003767, MONDO_0005575 | |
| Disease | electrocardiography | 3.73e-03 | 530 | 139 | 8 | EFO_0004327 | |
| Disease | QT interval | 3.90e-03 | 534 | 139 | 8 | EFO_0004682 | |
| Disease | schizophrenia (implicated_via_orthology) | 4.10e-03 | 68 | 139 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | coronary artery disease | TDRD15 FAT4 DNAH10 MAP1B MYO9B CARMIL1 RSPH6A EPG5 SERPINA1 SF3B3 KCNJ13 PLCB2 BSN | 4.29e-03 | 1194 | 139 | 13 | EFO_0001645 |
| Disease | kidney disease (biomarker_via_orthology) | 4.36e-03 | 21 | 139 | 2 | DOID:557 (biomarker_via_orthology) | |
| Disease | osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty | 4.36e-03 | 21 | 139 | 2 | EFO_0004616, EFO_0010726, EFO_1000786 | |
| Disease | bipolar I disorder | 4.52e-03 | 141 | 139 | 4 | EFO_0009963 | |
| Disease | autism spectrum disorder, schizophrenia | 4.64e-03 | 327 | 139 | 6 | EFO_0003756, MONDO_0005090 | |
| Disease | C-reactive protein measurement | TDRD15 SGIP1 MAP1A MTF2 CARMIL1 GRIA1 SPG11 CCDC168 FNBP1L SERPINA1 NUFIP2 BSN EIF4G3 | 4.66e-03 | 1206 | 139 | 13 | EFO_0004458 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DQQLVYSLPFKDMDK | 741 | Q8WWZ7 | |
| NFAIMTKYISKPENL | 241 | Q9H9S4 | |
| AQQPYSMEKLQVEFD | 671 | Q9HCE0 | |
| YQEAFEISKKEMQPT | 151 | P31946 | |
| DENKNVVLKVYPNMT | 451 | P12645 | |
| KMENNVIFYSKINTR | 511 | Q5SY80 | |
| NKPFVFLMIEQNTKS | 391 | P01009 | |
| DRTEYNQKLQEKMTP | 56 | Q9NXL2 | |
| KVRAKEQTFMFPENQ | 2566 | Q6V0I7 | |
| SFNPYKMLEELDKNS | 156 | Q6NTF7 | |
| IMFQYDKESTVPQNQ | 126 | Q8IZP9 | |
| YINMLKAKAEQNDLP | 246 | Q8IYW2 | |
| ASVDMVFSPKYNQKE | 361 | Q96K78 | |
| NNKMKNLSYPFSREK | 246 | Q9NQ90 | |
| NAKALQVMKQTLPYS | 171 | Q9Y483 | |
| YEKDVAKINQDPQVM | 521 | P36871 | |
| DMPKSDVNKEYYTQN | 106 | Q9NW64 | |
| PESYVAQMIKNKNLD | 2586 | Q14573 | |
| DNDPVTYVVQKQFMR | 891 | O15438 | |
| PMKVQNQEKAEELYQ | 226 | Q02297 | |
| QPVVSKQYTFKMNED | 2711 | Q01484 | |
| KQYTFKMNEDTQEEP | 2716 | Q01484 | |
| YQKPAQSSIQMDDKI | 386 | Q8IYW4 | |
| TPMQQKLNEVYEAVK | 656 | Q86U86 | |
| YVESENGQMYIQKKP | 36 | Q04759 | |
| SNFTMEDINNKKIRY | 1776 | Q86XX4 | |
| TSIYFKMENDLPQKI | 171 | P19256 | |
| YVLNPVKDSKEMQFL | 201 | P78559 | |
| NPVKSSKEMQYFMQQ | 426 | P46821 | |
| FPFTNKNQQKEMIET | 266 | Q9Y5Y7 | |
| YSTEEKPQQHQKTKM | 96 | Q8WWC4 | |
| FMKKLQPTVRNYVEN | 286 | P53779 | |
| ESLLNNNKQYMFPET | 396 | Q10469 | |
| DQNFKMPQEINYKEA | 146 | Q96IM9 | |
| KQFKSEAYQQQIEME | 6311 | Q03001 | |
| MSNPFLKQVFNKDKT | 1 | Q96BX8 | |
| KNEMLQFKIYDPNKN | 1046 | O43451 | |
| VKEQMFNELLTYNAP | 111 | O60760 | |
| KEKQFLNAESAYMDP | 1286 | Q9UPA5 | |
| YKSIMEQFNPALENL | 16 | Q6UXY1 | |
| QSLFTKYPLEQNQMI | 2441 | Q5CZC0 | |
| FNFLPMQINTNKSKD | 141 | Q15154 | |
| RAMFQKIVDESKNYQ | 676 | P35913 | |
| YQIKMENFDKTVPEF | 311 | O60928 | |
| PEAAKMLLQNYSKIQ | 556 | Q86UK5 | |
| YPQDELAMSKFNQQK | 436 | A6NHZ5 | |
| LAMSKFNQQKYDEIA | 441 | A6NHZ5 | |
| MNAIKESYDYNPNKT | 271 | O75530 | |
| MQNNEIIKPAKYFSE | 1 | Q96H12 | |
| AFKESAKQMLDPANY | 2041 | P46013 | |
| YPLFQQVVSKMDNIS | 116 | Q86WC4 | |
| QMVDVKENYQSTLPK | 51 | P20783 | |
| LQKKYMNEVYTNQPT | 356 | Q9H4K1 | |
| MAKIQKAVEYFQDNS | 116 | Q9UPT5 | |
| VKEANAYEFIMKLPQ | 506 | P21439 | |
| NKSNMVETLEQYKFV | 1416 | O14522 | |
| VMPNFSYSTDQNKVV | 256 | Q8WZ92 | |
| ETYKLLFNFVEQNMK | 656 | Q460N5 | |
| KSPMEFVEYNKQQLS | 631 | Q01970 | |
| EMNPNYTEFKFPQIK | 346 | P49840 | |
| DALNKMKDVYEKNPQ | 426 | Q5T0N5 | |
| SLNIDKIPEKNNDYM | 976 | P51587 | |
| QKLAYMELQQKAEFS | 696 | P49454 | |
| FLQQNPVTEYMKKAE | 251 | Q13616 | |
| NSVIEENEMKKPYQL | 511 | P43003 | |
| ENEMKKPYQLIAQDN | 516 | P43003 | |
| TDKVFSPKSNLQYKM | 1501 | Q15811 | |
| EEYNNISKKPMNLVL | 2301 | Q8WXX0 | |
| KMSPINMLYFNDKQQ | 376 | O95390 | |
| LYEDIPNMKNSNVVK | 396 | Q5VWK5 | |
| QYATQFLKRSKVQEM | 1156 | Q9ULL0 | |
| MYDASQALKTNPEKT | 636 | Q5VZK9 | |
| QMFNFYPKGTISKDN | 6441 | Q8NDH2 | |
| EDPYVMLKKNANQFE | 416 | P42261 | |
| NYMQSKQPSVFVKST | 691 | Q16478 | |
| NDPDFLKQLEMSIKY | 3461 | Q8IVF4 | |
| DFEKAKPRMDQYFNQ | 941 | O43432 | |
| KEYQFLKMTAVNETQ | 1626 | Q02224 | |
| DILKPYMKIFNQSAD | 166 | Q6NT55 | |
| FQVTNAMEKYSPKFE | 1241 | A6NMZ7 | |
| MLSVQNVFYRPKDKQ | 1011 | Q14562 | |
| NNKPNMVDLLDQYKF | 1426 | P28827 | |
| NFNQLYKIDPSTLQM | 846 | O15294 | |
| VKNYEGMIDNYKSQV | 536 | Q5BJF6 | |
| YAPSEKMITKVQDFQ | 111 | O14832 | |
| NVNMKYQLPNFTAET | 36 | P08581 | |
| QPTYKMAEKQKALFT | 266 | Q9H0K4 | |
| QKVVETMEKPFQYTA | 871 | Q5TCS8 | |
| QKTDSYFNPKMKLNR | 246 | Q7Z2T5 | |
| VSKAYKVNPDMNFEV | 161 | Q9HB90 | |
| YTPDMQKQFAEEQQK | 111 | Q9UMZ2 | |
| SVNLQNFPKYDSNKM | 1001 | B5MCY1 | |
| PSYDLQKVMAAIKQQ | 696 | Q6ZUX3 | |
| PDQKEYEKNNTTTLM | 616 | Q9H3W5 | |
| NSKYGTFVNEEKMQN | 71 | O60934 | |
| KTAEEFLQQMNYSKN | 311 | Q9Y6U3 | |
| QNPVKDSKEMFQTYK | 1716 | Q9HCM1 | |
| YINPKNSEEQKITEM | 901 | Q8NFP9 | |
| SVMFNFPDQATVKKV | 2236 | Q8NFP9 | |
| YKEKQMPKYSSENSN | 441 | P0CG39 | |
| FSNVKYVMLEENKQL | 826 | Q13635 | |
| KQFSQYIKNSVTPDM | 221 | P46777 | |
| RLNDETIKKYVPNMN | 2516 | O75592 | |
| KNNFLNIDPITMAYS | 41 | Q9UJM3 | |
| QMKTQQQFTKEYLET | 846 | Q8IWZ3 | |
| AEFQAKIDSIKQYMQ | 411 | Q16281 | |
| NFLDTLKNPEFNKMV | 1151 | A5YKK6 | |
| LKNPEFNKMVLNETY | 1156 | A5YKK6 | |
| DDPVNSAYNMKLAKF | 316 | Q96JI7 | |
| KQPSQAQRMYEKALQ | 251 | Q6DKK2 | |
| AVSNVMPEQLFKYQE | 546 | Q6ZU65 | |
| YTFSANDLEMKNPKV | 566 | A4D1E1 | |
| NAMKDYQDAITLNPK | 366 | Q86TZ1 | |
| QKQDPKRIITYNEAM | 676 | Q7Z417 | |
| EQKPQATYYNVDMLK | 661 | Q9BQI5 | |
| LFDPKDSVMQQNLVY | 321 | Q92791 | |
| IFQTETKQYMDQPKV | 776 | Q5SVQ8 | |
| TKQYMDQPKVYQSEA | 781 | Q5SVQ8 | |
| DQPKVYQSEAKTMLQ | 786 | Q5SVQ8 | |
| NEPKYKVVQDTYQIM | 121 | O14964 | |
| MNIYFPKKEAVTFDQ | 531 | Q9Y263 | |
| KLYQDDKQFVDMPLS | 46 | O43280 | |
| LGNLYPAFTKKMQQD | 121 | Q70EL3 | |
| PAFTKKMQQDAQEFL | 126 | Q70EL3 | |
| LYINSELQDFQKVPM | 1311 | O94813 | |
| APKKQALYLMFDTSQ | 2541 | O95359 | |
| EKYTPMEFKTLNKNN | 1091 | Q9P283 | |
| PYTEQTISLFQAMKK | 3911 | Q15149 | |
| SYQPQSMKNFEQAKI | 291 | Q9UGU0 | |
| FYMKPGQKTNQEILK | 1166 | Q86X10 | |
| EYQPSKNMFEKIHQE | 91 | Q15393 | |
| KSPVEFVEYNKMQLS | 581 | Q9NQ66 | |
| SKASVQFVDYNKRQM | 586 | Q00722 | |
| QQQDMYNKKIPSLFE | 571 | Q9UPT8 | |
| KEIKNSFNPEAQVFM | 126 | P50616 | |
| DPSQKNLYKDVMLEN | 26 | P51523 | |
| RDSLEPTYQQLQKMK | 176 | Q96AY4 | |
| FVKSLNKQMNPFIED | 551 | O43592 | |
| PQVQLFYELTDIMNK | 1221 | Q7Z7G8 | |
| SNTMVNKDDLPVSKY | 2086 | Q7Z7G8 | |
| ILNEYAEFNKVMKNS | 2111 | Q5VWN6 | |
| NKYDKSTFIIPQNMN | 251 | Q6ZMW2 | |
| YDSIKLMKDISQNFP | 326 | Q9NYU1 | |
| DLIYNMFKKVPTSNT | 5101 | Q5T4S7 | |
| KESPDMTKNFQQVDY | 276 | Q01085 | |
| KNPEQVDLYQFMAKD | 541 | P56192 | |
| TNQQFKSLPEYLENM | 511 | Q96FV9 | |
| EINYKEVPMTYKNNL | 106 | Q6ZNA1 | |
| QNMVEKFSQLPFKVE | 436 | O75113 | |
| EKFRSNIKTMYSVPN | 1541 | Q13459 | |
| ETPSYQASKEAQKMQ | 356 | O76041 | |
| MPDQNDVIQAKKAYE | 4091 | P20929 | |
| PKDSQLYKVMKDANN | 5811 | P20929 |